Juraj Velcicky

12PUBLICATIONS
34CO-AUTHORS
Evolutionary computationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Proteins and peptidesInnate immunityAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 20, 2026
A 24-Day MicroCycle Journey to Interleukin-17 Inhibitors: From Library Design to Central Core Prioritization and Capping Group Identification.

|Dec 08, 2025
Harnessing Glutamine-117 Plasticity toward Structure-Based Identification of Triazole IL-17 Inhibitors.

Matthias R Bauer, Juraj Velcicky, Alban Goetz

|Oct 15, 2025
Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement.

Juraj Velcicky, Jean-Baptiste Langlois, Michael Wright

|Feb 15, 2025
Discovery of selective low molecular weight interleukin-36 receptor antagonists by encoded library technologies.

Juraj Velcicky, Gregor Cremosnik, Clemens Scheufler

|Dec 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold Morphing.

Juraj Velcicky, Estelle Ngo, Matthias R Bauer

|Nov 22, 2024
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 Inflammasome.

Pageof 2

Frequent Collaborators

3 joint publications

Thomas Knoepfel

3 joint publications

Achim Schlapbach

2 joint publications

Angela Mackay

2 joint publications

Christopher J Farady